Singapore markets closed

JNJ Jun 2025 185.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.47000.0000 (0.00%)
As of 03:39PM EDT. Market open.
Full screen
Previous close1.4700
Open1.4800
Bid0.0000
Ask0.0000
Strike185.00
Expiry date2025-06-20
Day's range1.4700 - 1.4800
Contract rangeN/A
Volume2
Open interestN/A
  • Business Wire

    Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024

    NEW BRUNSWICK, N.J., July 17, 2024--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2024 of $1.24 per share on the company’s common stock. The dividend is payable on September 10, 2024 to shareholders of record at the close of business on August 27, 2024. The ex-dividend date is August 27, 2024.

  • Reuters

    J&J beats Wall Street estimates on strong drug sales

    (Reuters) -Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara. Revenue of $22.4 billion surpassed the consensus estimate of $22.3 billion, according to LSEG data. Adjusted earnings of $2.82 per share beat analysts' expectations of $2.70 per share.

  • Business Wire

    Johnson & Johnson reports Q2 2024 results

    NEW BRUNSWICK, N.J., July 17, 2024--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2024. "Johnson & Johnson's second quarter performance reflects our relentless focus on advancing the next wave of medical innovation and resulted in strong sales and adjusted operational earnings per share growth," said Joaquin Duato, Chairman and Chief Executive Officer. "With a robust pipeline, upcoming regulatory milestones for RYBREVANT and TREMFYA, the integration of Shockwave, and c